23 Jun Learn more about monkeypox as we record first confirmed case in SA
SamuelFrancisJohnson via Pixabay...
SAHPRA Tag
17 Jun The Dynamics of Assuming a New CEO or Leadership Role under Global Lockdown Restrictions
17 June 2022 CEO Perspectives and Horizons as Covid-19 takes a grip The SAHPRA CEO, Dr Boitumelo Semete-Makokotlela shares her journey since she assumed the position of CEO. She unpacks how she had to face a “sink or swim” situation as the COVID-19 pandemic gripped South Africa...
15 Jun Webinar: Codeine-Containing Medicines – Unpacking the dangers and abuse
Posted at 11:28h
in
SAHPRA hosted a Live Webinar: Codeine-Containing Medicines – Unpacking the Dangers of Irresponsible Behaviour and Abuse. Recording below: ...
07 Jun SAHPRA registers a vaccine and provides emergency use authorisation of health products in the fight against COVID-19
07 June 2022 Embargo: Immediate release1. The COVID-19 vaccine LHC has been registered with conditions on 24 May 2022.The registration of the COVID-19 vaccine LHC was done in terms of Section 15(6a) of the Medicines and Related Substance Act 101 of 1965. This COVID-19 vaccine (Sinopharm...
02 Jun Webinar: Launch of SAHPRA’s Online OTC Medicines’ directory
Posted at 11:06h
in
South African Health Products Regulatory Authority (SAHPRA) hosted a live webinar launching our new and first-of-its-kind Online Directory for over-the-counter (OTC) medicines in South Africa. When did it happen? 30 June 2022 Watch webinar recording below: ...
30 May SAHPRA statement on the termination of the “Ivermectin Controlled Compassionate Use Access Programme”
30 May 2022 Embargo: Immediate release Pretoria, 30 May 2022 - The use of Ivermectin for the treatment and prevention of COVID-19 received a lot of public interest in 2020. Early evidence, mostly from studies with a small number of patients and conducted with varying degrees...
27 May Update: SAHPRA Statement on the ANHP Judgement
27 May 2022 Embargo: Immediate release On 7 May 2022, the South African Health Products Regulatory Authority (SAHPRA) published a statement indicating that it would join the Minister of Health in approaching the Constitutional Court for leave to appeal the Supreme Court of Appeal (SCA) judgement...
17 May Regulatory experts from African countries visit the Paul-Ehrlich-Institut to discuss future cooperation with vaccine experts
17 May 2022 At a four-day meeting at the Paul-Ehrlich-Institut, representatives of the regulatory authorities in Ghana (Food and Drugs Authority, FDA), Rwanda (Food and Drugs Authority, FDA), South Africa (South African Health Products Regulatory Authority, SAHPRA) and Senegal (Agence sénégalaise de Réglementation Pharmaceutique, ARP) discussed future cooperation with vaccine...
12 May Safety of the COVID-19 Vaccine Janssen – response to restrictions imposed in the United States
12 May 2022Embargo: Immediate release In both the United States and South Africa, the COVID-19 Vaccine Janssen has been approved as a single primary vaccination dose, a single booster dose at least two months after the primary vaccination dose, and as a heterologous booster dose following...
07 May SAHPRA Statement on the ANHP Judgement
EKATERINA BOLOVTSOVA via Pexels...